These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8634919)

  • 1. Prevention of nitrate tolerance with concomitant administration of hydralazine.
    Elkayam U
    Can J Cardiol; 1996 May; 12 Suppl C():17C-21C. PubMed ID: 8634919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effects of glyceryl trinitrate: beyond vascular nitrate tolerance.
    Csont T; Ferdinandy P
    Pharmacol Ther; 2005 Jan; 105(1):57-68. PubMed ID: 15626455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine.
    Daiber A; Mülsch A; Hink U; Mollnau H; Warnholtz A; Oelze M; Münzel T
    Am J Cardiol; 2005 Oct; 96(7B):25i-36i. PubMed ID: 16226933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrate tolerance and dependence. A critical assessment.
    Abrams J
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2499-504. PubMed ID: 6775305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
    Elkayam U; Bitar F
    Am J Cardiol; 2005 Oct; 96(7B):37i-43i. PubMed ID: 16226934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and reversal of nitrate tolerance in patients with congestive heart failure.
    Packer M; Lee WH; Kessler PD; Gottlieb SS; Medina N; Yushak M
    N Engl J Med; 1987 Sep; 317(13):799-804. PubMed ID: 3114637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
    Bauer JA; Fung HL
    Circulation; 1991 Jul; 84(1):35-9. PubMed ID: 1905595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.
    Münzel T; Kurz S; Rajagopalan S; Thoenes M; Berrington WR; Thompson JA; Freeman BA; Harrison DG
    J Clin Invest; 1996 Sep; 98(6):1465-70. PubMed ID: 8823313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation of organic nitrates and the mechanism of nitrate tolerance.
    Klemenska E; Beresewicz A
    Cardiol J; 2009; 16(1):11-9. PubMed ID: 19130411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasodilator therapy in cardiac failure].
    Akatsuka N
    Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiol compounds and organic nitrates.
    Boesgaard S
    Dan Med Bull; 1995 Nov; 42(5):473-84. PubMed ID: 8747803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrate therapy in patients with coronary artery disease--preparations and doses with and without development of tolerance.
    Rudolph W; Dirschinger J; Kraus F; Reiniger G; Hall D
    Z Kardiol; 1990; 79 Suppl 3():57-65. PubMed ID: 2099042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.
    Thadani U
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):735-42. PubMed ID: 9110117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in the use of transdermal nitroglycerin systems.
    Zeller FP; Klamerus KJ
    Clin Pharm; 1987 Aug; 6(8):605-16. PubMed ID: 3121239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrate therapy for heart failure: benefits and strategies to overcome tolerance.
    Gupta D; Georgiopoulou VV; Kalogeropoulos AP; Marti CN; Yancy CW; Gheorghiade M; Fonarow GC; Konstam MA; Butler J
    JACC Heart Fail; 2013 Jun; 1(3):183-91. PubMed ID: 24621868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organic nitrate tolerance and endothelial dysfunction: role of folate therapy.
    Leopold JA; Loscalzo J
    Minerva Cardioangiol; 2003 Aug; 51(4):349-59. PubMed ID: 12900717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Organic nitrates: still interesting after all these years].
    Lisi M; Parker JD; Gori T
    Recenti Prog Med; 2009 Mar; 100(3):140-3. PubMed ID: 19475842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.